ABBOTT RECEIVES FDA APPROVAL FOR TENDYNE™, FIRST-OF-ITS-KIND DEVICE TO REPLACE THE MITRAL VALVE WITHOUT OPEN-HEART SURGERY

Reuters · 05/27 13:00

Please log in to view news